Figure 3

QLQ-C30 quality-of-life questionnaire-specific symptom scores for patients (n=22) before (week 0) and during outpatient immunotherapy (week 3). Higher scores represent a higher level of symptoms. aP⩽0.05; bP⩽0.01; cP⩽0.001 (Wilcoxon test). Nau/vom=nausea/vomiting; sleep dist.=sleep disturbance; app. loss=appetite loss; constip.=constipation.